… In current clinical practice, we can observe this relationship amongst others in patients with
… Although currently not ready for clinical practice, recent data have suggested that cardiac …

… disease, asymptomatic individuals at high risk of CVD mortality, first-degree relatives of
patients with premature CVD, and other individuals encountered in routine clinical practice. In the …

… Cardiovascular disease is generally due to a combination of several risk factors, and, in
recognition of the multi-factorial nature of this group of diseases… heart disease in clinical practice. …

… Large clinical trials have shown statin therapy to be effective and safe for primary
prevention of atherosclerotic cardiovascular disease (CVD) for adults age 40 to 75 years. …

Aims Most studies on the primary prevention of cardiovascular disease (CVD) have been
limited to patients at high CVD risk. We assessed the achievement of treatment goals for CVD …

… of patients at risk for the development of cardiovascular disease (CVD) and type 2 … clinical
practice for several reasons. The so-called classic risk factors are used in clinical practice to …

… The initial framework for atherosclerotic cardiovascular disease (ASCVD) risk assessment
began with the Framingham Heart Study, the longest running study of cardiovascular disease …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

… prevention of cardiovascular disease in ‘real-world’ clinical practice is currently unknown. …
assessment of cardiovascular risk in patients without known cardiovascular disease; (ii) …